February 27, 2020 / 1:13 PM / a month ago

BRIEF-Orchard Therapeutics Reports Qtrly Loss Per Share $0.46

Feb 27 (Reuters) - Orchard Therapeutics PLC:

* ORCHARD THERAPEUTICS REPORTS 2019 FINANCIAL RESULTS AND REVIEWS KEY STRATEGIC PRIORITIES FOR 2020

* ORCHARD THERAPEUTICS PLC - QTRLY LOSS PER SHARE $0.46

* ORCHARD THERAPEUTICS PLC - CASH, CASH EQUIVALENTS AND INVESTMENTS $325 MILLION AS OF DEC.31, 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below